Healthcare Innovation March 31, 2025
A new poll has industry leaders warning that tariffs will disrupt U.S. healthcare costs and supply chain stability
Two European-headquartered drugmakers indicated they are sending as many of their medicines across the Atlantic as possible. Michael Erman, Maggie Fick, and Lisa Baertlein reported for Reuters on March 27. The firms expressed fears that President Donald Trump’s April 2 tariffs announcement could include products made in Europe.
Trump has called April 2 “Liberation Day,” with promises to roll out a set of tariffs or taxes on imports from other countries, AP News’ Wyatte Grantham-Pilips reported on March 31.
Meanwhile, a survey conducted by Black Book Research illustrated concerns among healthcare supply chain professionals, pharmaceutical executives, distributors,...
Today's Sponsors
Today's Sponsor